CyPlus is proud to announce the finalization of the market ramp up in Mexico through its sales and distribution channel in Mexico so far separate from CyPlus Idesa. As a next step in organizational development the execution of sales and distribution of cyanides produced in Mexico for the precious metals mining industry is transferred to our Joint Venture CyPlus Idesa. With the move of your daily contacts for the countries Mexico, Belize, Costa Rica, El Salvador, Guatemala, Honduras, Nicaragua and Panama into this new organization we ensure the same high level of supply quality you have experienced with us in the last years. The transfer is subject to the time line for the announced changes in Evonik Industries - the sale of Evonik’s CyPlus business as part of the ‘Methacrylate-Verbund’ to Advent International - and the corresponding merger control.
Value explorers: Sustainable innovations beyond cyanides.
CyPlus is a regional leader in cyanides (NaCN and KCN) with strong technology services and is gearing towards positioning as innovative solution provider. Our Mission: We stand for safe and responsible handling of cyanides across their lifecycle from production, transport & handling to application and disposal. The Evonik subsidiary offerings encompass services for the entire cyanide life-cycle. New solution offerings with focus on productivity increase of mines with the potential to disruptively innovate the gold leaching process.
With approx. 100 employees worldwide, production sites in Europe and Mexico (CyPlus Idesa Joint Venture) as well as sales offices on all continents, we can ensure highest product quality, proximity to our customers and an optimum supply chain set up.
Evonik is one of the world leaders in specialty chemicals. The focus on more specialty businesses, customer-oriented innovative prowess and a trustful and performance-oriented corporate culture form the heart of Evonik’s corporate strategy. They are the lever for profitable growth and a sustained increase in the value of the company. Evonik benefits specifically from its customer proximity and leading market positions. Evonik is active in over 100 countries around the world with more than 36,000 employees. In fiscal 2018, the enterprise generated sales of €15 billion and an operating profit (adjusted EBITDA) of €2.6 billion.
In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.